Vyant Bio Inc (Vyant Bio), formerly Cancer Genetics Inc is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory services offer critical genomic information to healthcare professionals, biopharma companies, and cancer centers. CGI also provides clinical services such as expand DX, test menu, complete program, and summation report. It offers a range of pharmacogenomics testing services for clinical oncologists, cancer centers, and research institutions, and biotechnology and biopharmaceutical companies. The company works in research collaboration with cancer centers to develop and validate proprietary tests. Vyant Bio is headquartered in Rutherford, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vyant Bio Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Vyant Bio Inc Company Overview
- Vyant Bio Inc Company Snapshot
- Vyant Bio Inc Pipeline Products and Ongoing Clinical Trials Overview
- Vyant Bio Inc - Pipeline Analysis Overview
- Vyant Bio Inc - Key Facts
- Vyant Bio Inc - Major Products and Services
- Vyant Bio Inc Pipeline Products by Development Stage
- Vyant Bio Inc Pipeline Products Overview
- Cell Free DNA Assay - Kidney Cancer
- Cell Free DNA Assay - Kidney Cancer Product Overview
- Clinical Decision Assay - Multiple Myeloma
- Clinical Decision Assay - Multiple Myeloma Product Overview
- Clinical Decision Support Tool - Multiple Myeloma
- Clinical Decision Support Tool - Multiple Myeloma Product Overview
- Companion Diagnostic Test - Tavocept
- Companion Diagnostic Test - Tavocept Product Overview
- Comprehensive Pharmacogenomics Panel Test
- Comprehensive Pharmacogenomics Panel Test Product Overview
- EGFR Mutation Diagnostic Test
- EGFR Mutation Diagnostic Test Product Overview
- FHACT Test - Head and Neck Cancer
- FHACT Test - Head and Neck Cancer Product Overview
- FReCaD Renal Cancer Test
- FReCaD Renal Cancer Test Product Overview
- LeukA - Leukemia
- LeukA - Leukemia Product Overview
- MatBA Diagnostic Test Marginal Zone Lymphoma
- MatBA Diagnostic Test Marginal Zone Lymphoma Product Overview
- MatBA Diagnostic Test - Multiple Myeloma
- MatBA Diagnostic Test - Multiple Myeloma Product Overview
- UGenRA - Cervix
- UGenRA - Cervix Product Overview
- UGenRA - Endometrium
- UGenRA - Endometrium Product Overview
- UGenRA - Ovarian Cancer
- UGenRA - Ovarian Cancer Product Overview
- UroGenRA - Bladder
- UroGenRA - Bladder Product Overview
- UroGenRA - Prostate
- UroGenRA - Prostate Product Overview
- Vyant Bio Inc - Key Competitors
- Vyant Bio Inc - Key Employees
- Vyant Bio Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Twist Bioscience Corp
- Five Prime Therapeutics Inc
- Celcuity Inc
- CASI Pharmaceuticals Inc